The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.21, Iss.1-2, 2002-01, pp. : 1-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorouracil: Intestinal disorders in a patient with dihydropyrimidine dehydrogenase deficiency: case report

Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K Soong Richie Diasio Robert B

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

By Amstutz Ursula Froehlich Tanja K Largiadèr Carlo R

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1321-1336

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment

By Amstutz Ursula Farese Simone Aebi Stefan Largiadèèr Carlo R

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 931-944

Future Medicine

Access to resources Recommend Favorite